6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization
Key Takeaways
- The cardiovascular response to severe burn trauma (≥20% TBSA) is biphasic: an initial hypodynamic Ebb/Resuscitation Phase (0–48 hours) marked by severe reduction in cardiac output (often 30–50% drop) and high systemic vascular resistance (SVR), followed by a prolonged hyperdynamic Flow Phase (>48–72 hours) with cardiac output reaching 1.5 to 2.5 times baseline.
- Early post-burn myocardial depression occurs immediately following thermal injury and precedes significant plasma volume loss; it is mediated by circulating myocardial depressant factors (TNF-alpha, IL-1beta, IL-6, reactive oxygen species) and impaired sarcoplasmic reticulum intracellular calcium handling.
- Continuous arterial line catheterization is mandatory in extensive burns for beat-to-beat systemic blood pressure monitoring, arterial blood gas sampling, and dynamic pulse pressure / stroke volume variation analysis, as non-invasive cuff measurements are notoriously inaccurate due to progressive interstitial extremity edema.
- Advanced hemodynamic monitoring modalities (such as transpulmonary thermodilution [PiCCO], pulse contour analysis [FloTrac/EV1000], and point-of-care echocardiography) provide functional preload indices (Stroke Volume Variation [SVV] and Pulse Pressure Variation [PPV]) that superiorly guide fluid titration compared to static central venous pressure (CVP) values.
- Intravascular fluid resuscitation remains the primary foundational therapy for burn shock; vasopressors (e.g., norepinephrine, vasopressin) are indicated only for refractory distributive vasodilation after intravascular volume has been restored. Pure alpha-1 adrenergic agonists (phenylephrine) and high-dose epinephrine must be avoided due to profound splanchnic and dermal microvascular vasoconstriction that accelerates tissue necrosis in Jackson's zone of stasis.
6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization
Core Knowledge: Major thermal trauma involving $\ge 20%$ Total Body Surface Area (TBSA) precipitates profound, life-threatening cardiovascular instability. Unlike standard hypovolemic shock, burn shock represents a complex hybrid of hypovolemic, distributive, and cardiogenic shock mechanisms. Understanding the transition from the initial hypodynamic ebb phase to the persistent hyperdynamic flow phase, recognizing intrinsic myocardial depression, and deploying advanced hemodynamic monitoring are critical competencies for the Certified Burn Registered Nurse (CBRN).
1. The Biphasic Cardiovascular Paradigm in Severe Burns
Thermal trauma induces an immediate, systemic neuroendocrine, inflammatory, and microvascular storm that divides the patient's cardiovascular course into two distinct physiological phases: the Ebb (Resuscitation) Phase and the Flow (Hypermetabolic) Phase.
BIPHASIC CARDIOVASCULAR TRAJECTORY IN SEVERE BURNS
┌────────────────────────────────────────┬────────────────────────────────────────┐
│ EBB / RESUSCITATION PHASE │ FLOW / HYPERMETABOLIC PHASE │
│ (0 – 48 Hours) │ (>48 – 72 Hours) │
├────────────────────────────────────────┼────────────────────────────────────────┤
│ • Cardiac Output: Markedly decreased │ • Cardiac Output: Markedly elevated │
│ (30–50% drop below baseline) │ (1.5–2.5x normal baseline; 10-18 L/m)│
│ • SVR: Markedly elevated (vasospasm) │ • SVR: Low to normal (vasodilation) │
│ • Heart Rate: Moderate tachycardia │ • Heart Rate: Severe tachycardia │
│ • Stroke Volume: Severely reduced │ • Stroke Volume: Normal to supranormal │
│ • Intravascular Volume: Severe deficit │ • Intravascular Volume: Stabilizing │
│ • Oxygen Delivery (DO2): Depressed │ • Oxygen Delivery (DO2): Supranormal │
│ • Splanchnic Flow: Severely restricted │ • Splanchnic Flow: Hyperemic │
└────────────────────────────────────────┴────────────────────────────────────────┘
The Hypodynamic Ebb Phase (0 to 48 Hours)
During the initial 24 to 48 hours post-injury, the cardiovascular system is characterized by severe hypoperfusion and cellular energy deprivation:
- Cardiac Output (CO): Plummets by 30% to 50% within minutes of injury, reaching nadirs well before substantial intravascular fluid volume has been lost to the interstitial spaces.
- Systemic Vascular Resistance (SVR): Spikes dramatically. The massive release of endogenous catecholamines (epinephrine and norepinephrine), vasopressin, angiotensin II, and thromboxane $A_2$ causes intense peripheral and splanchnic vasoconstriction in an effort to maintain central mean arterial pressure (MAP).
- Hemoconcentration: Extensive plasma extravasation through hyperpermeable capillary beds increases blood viscosity and hematocrit (often 50% to 65%), creating microvascular sludging and elevating myocardial afterload.
The Hyperdynamic Flow Phase (>48 to 72 Hours to Months)
As capillary integrity is restored and interstitial third-space fluid begins to resorb into the intravascular compartment, the body transitions into the hypermetabolic flow phase:
- Supranormal Cardiac Output: Cardiac output surges to 150% to 250% of normal baseline (frequently 10 to 18 L/min; cardiac index 4.5 to 7.0 L/min/m²). This state can persist for 12 to 24 months post-injury.
- Systemic Vascular Resistance: Decreases significantly due to peripheral vasodilation driven by sustained inflammatory mediators, elevated core body temperature setpoints (~38.5°C), and profound tissue metabolic demand.
- Wide Pulse Pressures & Tachycardia: Baseline resting heart rates commonly exceed 110 to 130 beats/min in adults, accompanied by bounding peripheral pulses and wide pulse pressures.
2. Pathophysiology of Early Burn Myocardial Depression
A hallmark of burn shock that distinguishes it from pure hemorrhagic shock is early intrinsic myocardial depression. Experimental and clinical studies demonstrate that left and right ventricular contractility drops precipitously within 1 to 2 hours of thermal injury, even when left ventricular end-diastolic volume (preload) is artificially maintained with rapid volume infusions.
MECHANISMS OF BURN MYOCARDIAL DEPRESSION
┌────────────────────────────────────────────────────────────────────────────────────────┐
│ Circulating Myocardial Depressant Factors (MDF): TNF-α, IL-1β, IL-6, Endothelin-1 │
│ │ │
│ ▼ │
│ Disrupted Sarcoplasmic Reticulum Ryanodine Receptors & Downregulated SERCA2a Pumps │
│ │ │
│ ▼ │
│ Impaired Intracellular Calcium Cycling & Sarcoplasmic Ca2+ Influx During Systole │
│ │ │
│ ▼ │
│ Excessive Catecholamine Surge ──► Beta-Adrenergic Receptor Uncoupling & Desensitization│
│ │ │
│ ▼ │
│ Myocardial Oxidative Stress, Lipid Peroxidation & Depressed Myofibrillar ATP Delivery │
│ │ │
│ ▼ │
│ PRECIPITOUS DROP IN LEFT VENTRICULAR STROKE WORK INDEX (LVSWI) & EF │
└────────────────────────────────────────────────────────────────────────────────────────┘
Key Molecular Mechanisms:
- Myocardial Depressant Cytokines: Pro-inflammatory cytokines—primarily Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1beta (IL-1β), and Interleukin-6 (IL-6)—exert direct negative inotropic effects on cardiac myocytes. They induce inducible nitric oxide synthase (iNOS), producing excess nitric oxide and peroxynitrite that depress myofibrillar responsiveness to calcium.
- Disrupted Calcium Homeostasis: Thermal trauma causes severe dysregulation of the sarcoplasmic reticulum calcium ATPase (SERCA2a) and ryanodine receptors. Intracellular calcium transient amplitude is diminished during systole, resulting in impaired cross-bridge cycling and reduced force generation.
- Beta-Adrenergic Desensitization: Massive systemic levels of circulating epinephrine and norepinephrine saturate and uncouple myocardial beta-1 adrenergic receptors via G-protein receptor kinase (GRK) phosphorylation, rendering the myocardium relatively refractory to endogenous adrenergic stimulation.
- Oxidative Myocardial Injury: Free radicals generated by xanthine oxidase and activated neutrophils induce lipid peroxidation of myocardial cell membranes and mitochondrial dysfunction, lowering cellular ATP generation.
3. Hemodynamic Monitoring Modalities in the Burn ICU
Accurate assessment of volume status, ventricular performance, and tissue perfusion is essential to navigate the narrow therapeutic corridor between under-resuscitation (leading to hypoperfusion, acute tubular necrosis, and burn conversion) and over-resuscitation (leading to fluid creep, pulmonary edema, and abdominal compartment syndrome).
| Monitoring Modality | Clinical Utility in Burns | Limitations & Technical Considerations |
|---|---|---|
| Invasive Arterial Line | Beat-to-beat blood pressure; serial arterial blood gases (ABG), lactate, and base deficit; continuous pulse contour waveform analysis. | Mandatory in burns $\ge 20%$ TBSA. Non-invasive cuff pressures significantly overestimate true intra-arterial pressure in the presence of severe edema. |
| Central Venous Catheter (CVC) | Central venous pressure (CVP) trends; central venous oxygen saturation ($ScvO_2$); central vasoactive drug infusion. | Static CVP values (mmHg) correlate poorly with true preload and fluid responsiveness. Useful primarily for continuous $ScvO_2$ monitoring (target $\ge 70%$). |
| Transpulmonary Thermodilution (PiCCO / EV1000) | Measures Extravascular Lung Water Index (EVLWI), Global End-Diastolic Volume Index (GEDVI), and continuous Cardiac Index (CI). | Highly valuable in massive burns and inhalation injury. EVLWI directly quantifies pulmonary capillary leak and impending ARDS. |
| Pulse Contour Analysis (FloTrac / Vigileo) | Real-time Stroke Volume (SV), Cardiac Output (CO), and dynamic fluid responsiveness indices (SVV / PPV). | Requires an arterial line. Accurate only in patients in sinus rhythm who are fully mechanically ventilated with fixed tidal volumes ($\ge 8\text{ mL/kg}$). |
| Point-of-Care Echocardiography (TTE / TEE) | Visualizes biventricular systolic function, chamber dimensions, inferior vena cava (IVC) collapsibility/distensibility, and pericardial effusion. | Operator-dependent; chest wall dressings, thoracic eschar, and subcutaneous emphysema can compromise transthoracic acoustic windows. |
4. Static vs. Dynamic Indices of Fluid Responsiveness
Traditional static markers of volume (e.g., CVP, Pulmonary Capillary Wedge Pressure [PCWP]) have proven notoriously unreliable in critical burn care because altered chest wall compliance (circumferential torso eschar), positive-pressure mechanical ventilation, and myocardial stiffness distort pressure-volume relationships.
DYNAMIC INDICES FOR FLUID RESPONSIVENESS IN THE BURN ICU
┌────────────────────────────────────────────────────────────────────────────────────────┐
│ Stroke Volume Variation (SVV) / Pulse Pressure Variation (PPV): │
│ │
│ SVV = (SV_max - SV_min) / [(SV_max + SV_min) / 2] x 100% │
│ │
│ • SVV / PPV > 12–13%: Patient is on the steep portion of the Frank-Starling curve; │
│ highly likely to increase stroke volume and cardiac output in response to fluid. │
│ • SVV / PPV < 10%: Patient is on the flat plateau of the Frank-Starling curve; │
│ additional crystalloids will NOT augment cardiac output, but WILL worsen edema. │
│ │
│ PREREQUISITES FOR ACCURATE DYNAMIC MONITORING: │
│ [1] Controlled mechanical ventilation with no spontaneous breathing efforts │
│ [2] Tidal volume ≥ 8 mL/kg of predicted body weight (PBW) │
│ [3] Absence of cardiac dysrhythmias (atrial fibrillation, frequent PVCs) │
│ [4] Closed chest cavity (no open thoracic trauma or massive pneumothorax) │
└────────────────────────────────────────────────────────────────────────────────────────┘
5. Vasoactive and Inotropic Pharmacotherapy Principles
In acute burn shock, fluid resuscitation is the primary intervention. Vasopressors must never be used as a substitute for adequate intravascular crystalloid volume repletion.
[!CRITICAL] Administering vasopressors to an unresuscitated, hypovolemic burn patient produces catastrophic peripheral and splanchnic microvascular collapse. Intense alpha-1 vasoconstriction turns viable, stasis-injured dermis into full-thickness necrotic tissue (burn depth conversion) and precipitates ischemic gut necrosis.
VASOPRESSOR & INOTROPE ALGORITHM
┌──────────────────────────────────────────────────────────────────────────────────────┐
│ Hypotension / Hypoperfusion (MAP < 65 mmHg, Lactate > 2) │
└──────────────────────────────────────────┬───────────────────────────────────────────┘
│
▼
┌──────────────────────────────────────────────────────────────────────────────────────┐
│ FIRST: Optimize Intravascular Preload (Titrate LR, SVV > 12%, ScvO2) │
└──────────────────────────────────────────┬───────────────────────────────────────────┘
│
┌──────────────────────────┴──────────────────────────┐
▼ ▼
┌────────────────────────┐ ┌────────────────────────┐
│ Persistent Vasodilation│ │ Depressed Myocardial │
│ (Low SVR, Normal SVV) │ │ Contractility / ScvO2 │
└────────────┬───────────┘ └───────────┬────────────┘
│ │
▼ ▼
┌────────────────────────┐ ┌────────────────────────┐
│ 1st Line: NOREPINEPHRINE│ │ 1st Line: DOBUTAMINE │
│ (Potent α1 + moderate │ │ (β1 inotrope: augments │
│ β1 inotrope support) │ │ stroke volume & DO2) │
│ │ │ │
│ 2nd Line: VASOPRESSIN │ │ 2nd Line: MILRINONE │
│ (0.03–0.04 units/min; │ │ (Inodilator: PDE-3 │
│ restores V1 tone) │ │ inhibitor; caution │
│ │ │ with hypotension) │
│ STRICTLY AVOID: │ └────────────────────────┘
│ • Phenylephrine (pure │
│ α1 micro-ischemia) │
│ • High-dose Epinephrine│
│ (lactic acidosis) │
└────────────────────────┘
1. Norepinephrine (First-Line Vasopressor)
- Receptor Target: Strong alpha-1 adrenergic vasoconstriction with moderate beta-1 inotropic and chronotropic activity.
- Indication: Refractory hypotension (MAP $<65\text{ mmHg}$) caused by early distributive SIRS or late septic vasodilation, occurring after dynamic preload indicators confirm adequate volume resuscitation.
- Clinical Benefit: Restores perfusion pressure to vital organs without inducing the extreme tachyarrhythmias and hyperlactatemia seen with epinephrine infusions.
2. Vasopressin (Second-Line / Adjunctive Vasopressor)
- Receptor Target: Direct vascular $V_1$ receptor agonist.
- Indication: Refractory vasodilatory shock as an adjunct to norepinephrine at a fixed rate of 0.03 to 0.04 units/min.
- Clinical Benefit: Circumvents adrenergic receptor down-regulation and blunts excessive sympathetic vasoconstriction in the pulmonary vascular bed.
3. Dobutamine (First-Line Inotrope)
- Receptor Target: Potent beta-1 agonist with mild beta-2 and alpha-1 activity.
- Indication: Persistent tissue hypoperfusion (low $ScvO_2 < 70%$, elevated lactate) accompanied by echocardiographic evidence of depressed left ventricular contractility despite optimized intravascular volume and normalized MAP.
- Dosing: Initiated at 2.5 to 10 mcg/kg/min.
4. Agents to Strictly Avoid in Acute Burn Resuscitation
- Phenylephrine: Pure alpha-1 agonist with zero inotropic activity. Causes intense cutaneous and mesenteric arteriolar constriction, converting partial-thickness burns into non-viable full-thickness wounds in Jackson's zone of stasis and starving the gastrointestinal mucosa.
- High-Dose Epinephrine: Induces severe tachycardia, escalates myocardial oxygen consumption ($MVO_2$), triggers splanchnic vasoconstriction, and stimulates excessive skeletal muscle aerobic glycolysis via beta-2 receptors, resulting in confusing, non-hypoxic lactic acidosis.
A 45-year-old male with a 50% TBSA flame burn is admitted to the burn ICU. At post-burn hour 3, invasive arterial monitoring reveals a blood pressure of 82/48 mmHg (MAP 59 mmHg) and HR 124 bpm. Fluid resuscitation is progressing on schedule according to the Parkland formula. Dynamic monitoring demonstrates a Stroke Volume Variation (SVV) of 19% and a Central Venous Oxygen Saturation (ScvO2) of 56%. What is the most appropriate next intervention?
During the first 24 hours of burn shock resuscitation, which mechanism is primarily responsible for the marked reduction in cardiac output that occurs even before significant plasma volume loss is established?
A patient with a 40% TBSA thermal injury is on post-burn day 4 in the hypermetabolic flow phase. The nurse assesses a blood pressure of 88/44 mmHg, HR 122 bpm, CVP 9 mmHg, and dynamic Stroke Volume Variation (SVV) of 8%. The patient has received adequate fluid resuscitation and exhibits bounding peripheral pulses and warm extremities. Which vasoactive strategy is most appropriate?